TRITANRIX HEPB injection suspension GLAXO SMITH KLINE
Chemical substance: DTPA + HEPB combination vaccine
ATC code: J07CA05 • Antiinfectives for systemic use | Bacterial and viral vaccines, combined
Active substance
Results for the substance dtpa hepb combination vaccine
2 results
About this active substance
The combined DTPa+HepB vaccine is used for active immunization against diphtheria, tetanus, pertussis (whooping cough), and hepatitis B. This vaccine contains acellular components of Bordetella pertussis, diphtheria and tetanus toxoids, and the hepatitis B surface antigen.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. It is essential for preventing serious diseases such as chronic hepatitis B, liver cirrhosis, and liver cancer, as well as complications associated with diphtheria, tetanus, and whooping cough.
Common side effects include fever, irritability, drowsiness, and pain at the injection site. In rare cases, severe allergic reactions may occur.
The combined DTPa+HepB vaccine is a crucial measure for protecting public health, helping to reduce the incidence of these infectious diseases and prevent severe complications associated with them.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. It is essential for preventing serious diseases such as chronic hepatitis B, liver cirrhosis, and liver cancer, as well as complications associated with diphtheria, tetanus, and whooping cough.
Common side effects include fever, irritability, drowsiness, and pain at the injection site. In rare cases, severe allergic reactions may occur.
The combined DTPa+HepB vaccine is a crucial measure for protecting public health, helping to reduce the incidence of these infectious diseases and prevent severe complications associated with them.